Segui
Paolo Guazzi
Paolo Guazzi
COO, HansaBioMed Life Sciences
Email verificata su hansabiomed.eu - Home page
Titolo
Citata da
Citata da
Anno
Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches
N Zarovni, A Corrado, P Guazzi, D Zocco, E Lari, G Radano, J Muhhina, ...
Methods 87, 46-58, 2015
5022015
Structural and functional differences between KRIT1A and KRIT1B isoforms: a framework for understanding CCM pathogenesis
F Francalanci, M Avolio, E De Luca, D Longo, V Menchise, P Guazzi, ...
Experimental Cell Research 315 (2), 285-303, 2009
592009
Identification of the Kelch family protein Nd1-L as a novel molecular interactor of KRIT1
P Guazzi, L Goitre, E Ferro, V Cutano, C Martino, L Trabalzini, SF Retta
Public Library of Science 7 (9), e44705, 2012
392012
G-protein binding features and regulation of the RalGDS family member, RGL2
E Ferro, D Magrini, P Guazzi, TH Fischer, S Pistolesi, R Pogni, GC White, ...
Biochemical Journal 415 (1), 145-154, 2008
132008
TM9SF4 expression in tumor tissues: a novel diagnostic biomarker for gastrointestinal tumors
P Guazzi, D Zocco, S Isajevs, N Zarovni, L Bianciardi, M Toots, A Sivins, ...
Translational Cancer Research 9 (11), 6652, 2020
42020
Use of TM9SF4 as a biomarker for tumor associated exosomes
F Lozupone, A Chiesi, P Guazzi, N Zarovni, P Ferruzzi, D Zocco
US Patent App. 15/316,188, 2017
32017
Use of TM9SF4 as a biomarker for tumor associated exosomes
F Lozupone, A Chiesi, P Guazzi, N Zarovni, P Ferruzzi, D Zocco
US Patent App. 17/737,453, 2022
2022
CD9a expression in premalignant lesions, gastric and colorectal carcinoma
S Isajevs, F Lozupone, N Zarovni, A Chiesi, P Guazzi, M Leja
Pathology 49, S134, 2017
2017
Identification of a novel KRIT1 interactor involved in the control of actin cytoskeleton dynamics and cell resistance to oxidative stress
P Guazzi, L Goitre, E Ferro, V Cutano, C Martino, L Trabalzini, SF Retta
IVBM 2012 2012, 21-21, 2012
2012
Identification of a novel KRIT1 interactor involved in the control of actin cytoskeleton dynamics and cell resistance to oxidative stress
L Trabalzini, P Guazzi, L Goitre, V Cutano, E Ferro, C Martino, SF Retta
Pathobiology of CCM, ---, 2011
2011
Identification of a novel KRIT1 interactor involved in the control of actin cytoskeleton dynamics.
P Guazzi, E Ferro, L Goitre, C Martino, V Cutano, C Bettini, SF Retta, ...
Atti 55th National Meeting of the Italian Society of Biochemistry and …, 2010
2010
Novel signaling pathways regulating KRIT1 nucleocytoplasmic shuttling and its role in CCM pathogenesis.
L Goitre, F Balzac, F Francalanci, M Avolio, V Menchise, P Guazzi, ...
V° Angioma Alliance scientific workshop on the Pathobiology of Cerebral …, 2009
2009
Structural and functional differences of Krit1A and Krit1B isoforms: a framework for understanding CCM pathogenesis. IX Convegno FISV (Federazione Italiana Scienze della Vita …
F Francalanci, M Avolio, L Goitre, P Guazzi, E Ferro, G Tarone, SF Retta
IX Convegno FISV (Federazione Italiana Scienze della Vita). 20, xx-xx, 2007
2007
The N-terminal and C-terminal domains of KRIT1 protein may regulate its localization in distinct subcellular compartments
E Ferro, P Guazzi, F Francalanci, M Avolio, M Marino, E DE LUCA, ...
Convegno ABCD su “Membrane Traffic and Organelle Biogenesis” 20, xx-xx, 2007
2007
Structural and functional differences of Krit1A and Krit1B isoforms: a framework for understanding CCM pathogenesis
P Guazzi, F Francalanci, M Avolio, E Ferro, M Marino, E DE LUCA, ...
52° Congresso della Società Italiana di Biochimica e Biologia Molecolare …, 2007
2007
The FERM domain of Krit1 protein may interact with protein with different subcellular localization
E Ferro, F Francalanci, P Guazzi, SF Retta, L Trabalzini
51° Congresso della Società Italiana di Biochimica e Biologia Molecolare …, 2006
2006
NOVEL MOLECULAR INTERACTIONS OF KRIT1, A PROTEIN INVOLVED IN CEREBRAL CAVERNOUS MALFORMATIONS
P Guazzi, E Ferro, C Bettini, L Goitre, V Cutano, C Martino, SF Retta, ...
BIOTECNOLOGIE MEDICHE, 26, 0
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–17